Literature DB >> 11156493

Session 2: clinical aspects. Clinical assessment of hand OA.

M C Hochberg1, E Vignon, E Maheu.   

Abstract

The aim of the session was to discuss the current definitions of and criteria for hand osteoarthritis (OA) and to review the tools proposed for the clinical assessment of hand OA in research and trials. The American College of Rheumatology criteria for the classification and reporting of hand OA were discussed and their limitations noted; specifically, they are designed for symptomatic OA and based on physical examination. The differences between erosive and non-erosive hand OA were discussed as was the relationship between hand OA and generalized OA, since hand OA represents a generalized OA of hand joints and can be considered as a marker for developing generalized OA (i.e. OA at other sites). Different clinical tools to assess patients were presented and discussed, such as pain assessment, Dreiser's functional index or Bellamy's AUSCAN for function assessment, assessment of the mobility, stiffness, inflammation and aesthetic damages. The agreements, disagreements and further studies to be performed to answer questions still debated are presented.

Entities:  

Mesh:

Year:  2000        PMID: 11156493     DOI: 10.1053/joca.2000.0335

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  8 in total

1.  Activity limitations and participation restrictions in women with hand osteoarthritis: patients' descriptions and associations between dimensions of functioning.

Authors:  I Kjeken; H Dagfinrud; B Slatkowsky-Christensen; P Mowinckel; T Uhlig; T K Kvien; A Finset
Journal:  Ann Rheum Dis       Date:  2005-04-13       Impact factor: 19.103

Review 2.  [Health-related quality of life (HRQoL) in rheumatoid arthritis].

Authors:  T Stamm
Journal:  Z Rheumatol       Date:  2010-05       Impact factor: 1.372

3.  Choosing between NSAID and arnica for topical treatment of hand osteoarthritis in a randomised, double-blind study.

Authors:  Reto Widrig; Andy Suter; Reinhard Saller; Jörg Melzer
Journal:  Rheumatol Int       Date:  2007-02-22       Impact factor: 2.631

Review 4.  [Clinical outcome measures in hand- and finger joint osteoarthritis from the patient perspective].

Authors:  T Stamm; K Machold; D Aletaha; G Stucki; J Smolen
Journal:  Z Rheumatol       Date:  2006-03       Impact factor: 1.372

5.  Research in hand osteoarthritis: time for reappraisal and demand for new strategies. An opinion paper.

Authors:  Margreet Kloppenburg; Tanja Stamm; Iain Watt; Franz Kainberger; Tim E Cawston; Fraser N Birrell; Ingemar F Petersson; Tore Saxne; Tore K Kvien; Barbara Slatkowsky-Christensen; Maxime Dougados; Laure Gossec; Ferdinand C Breedveld; Josef S Smolen
Journal:  Ann Rheum Dis       Date:  2007-03-14       Impact factor: 19.103

6.  How Hand Osteoarthritis, Comorbidity, and Pain Interact to Determine Functional Limitation in Older People: Observations From the European Project on OSteoArthritis Study.

Authors:  Paola Siviero; Sabina Zambon; Federica Limongi; Maria Victoria Castell; Cyrus Cooper; Dorly J H Deeg; Michael D Denkinger; Elaine M Dennison; Mark H Edwards; Antonella Gesmundo; Ángel Otero; Nancy L Pedersen; Richard Peter; Rocio Queipo; Erik J Timmermans; Natasja M van Schoor; Stefania Maggi
Journal:  Arthritis Rheumatol       Date:  2016-11       Impact factor: 10.995

7.  A comparison of the modified score for the assessment of chronic rheumatoid affections of the hands and the australian/canadian osteoarthritis hand index in hand osteoarthritis patients.

Authors:  Judith Sautner; Ingrid Andel; Bernhard Rintelen; Burkhard F Leeb
Journal:  Int J Rheumatol       Date:  2009-02-10

8.  Common Upper Extremity Disorders and Function Affect Upper Extremity-Related Quality of Life: A Community-Based Sample from Rural Areas.

Authors:  Dong Kyu Moon; Young Jin Park; Sang Youn Song; Mi Ji Kim; Jin Sung Park; Dae Cheol Nam; Dong Hee Kim; Jae Boem Na; Sang Il Lee; Sun Chul Hwang; Ki Soo Park
Journal:  Yonsei Med J       Date:  2018-07       Impact factor: 2.759

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.